In July 2025, former U.S. President Donald Trump sent letters to the CEOs of 17 major pharmaceutical companies urging them to lower prescription drug costs for Americans.
True
U. S. President Donald Trump sent letters to the chief executives of 17 major pharmaceutical companies, urging immediate action to lower the cost of prescription drugs for Americans
Tariffs in the second Trump administration - Wikipedia
Source: en.wikipedia.org
At a glance
Verified July 31, 2025Key Evidence
Reports from Investing.com and Raw Story detail that President Trump sent letters demanding drug price reductions within 60 days and threatened enforcement actions.
Pravda EN confirms the call for MFN pricing to provide immediate relief from high drug costs.
Reuters notes pharmaceutical companies like GSK are engaging with the Trump administration on drug pricing reforms.
The reporting
What the Evidence Shows
Multiple credible sources from July 2025 confirm that Donald Trump, who is identified as the U.S. President in these reports, sent letters to the chief executives of 17 major pharmaceutical companies. These letters demanded immediate action to reduce the high cost of prescription drugs in the United States, including a call to implement Most-Favored-Nation (MFN) pricing and a 60-day deadline for compliance.
The letters also included warnings that the administration would use all available tools to enforce these demands if necessary. This action is part of ongoing efforts during Trump's second presidency, which began prior to or during 2025, to address drug pricing issues. The consistency across multiple news outlets and the timing in mid-2025 support the accuracy of this claim.
Primary trail
Verified Sources6
Open source